GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Akumin Inc (OTCPK:AKUMQ) » Definitions » Cash Conversion Cycle

Akumin (Akumin) Cash Conversion Cycle : 30.03 (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Akumin Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Akumin's Days Sales Outstanding for the three months ended in Sep. 2023 was 59.08.
Akumin's Days Inventory for the three months ended in Sep. 2023 was 0.
Akumin's Days Payable for the three months ended in Sep. 2023 was 29.05.
Therefore, Akumin's Cash Conversion Cycle (CCC) for the three months ended in Sep. 2023 was 30.03.


Akumin Cash Conversion Cycle Historical Data

The historical data trend for Akumin's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akumin Cash Conversion Cycle Chart

Akumin Annual Data
Trend Sep15 Sep16 Sep17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash Conversion Cycle
Get a 7-Day Free Trial 0.16 34.09 52.23 53.77 36.10

Akumin Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.77 35.83 37.45 37.02 30.03

Competitive Comparison of Akumin's Cash Conversion Cycle

For the Diagnostics & Research subindustry, Akumin's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akumin's Cash Conversion Cycle Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Akumin's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Akumin's Cash Conversion Cycle falls into.



Akumin Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Akumin's Cash Conversion Cycle for the fiscal year that ended in Dec. 2022 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=57.38+0-21.28
=36.10

Akumin's Cash Conversion Cycle for the quarter that ended in Sep. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=59.08+0-29.05
=30.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Akumin  (OTCPK:AKUMQ) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Akumin Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Akumin's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Akumin (Akumin) Business Description

Traded in Other Exchanges
Address
8300 West Sunrise Boulevard, Plantation, FL, USA, 33322
Akumin Inc is a Canada-based company that provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company operates in Florida, Pennsylvania, Delaware, Texas, Illinois, and Kansas. It offers physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and may reduce unnecessary invasive procedures, minimizing the cost and amount of care for patients. The company's imaging procedures include MRI, CT, positron emission tomography, ultrasound, X-ray, mammography, and other diagnostic or interventional radiology procedures. It operates in two reportable business segments: radiology and oncology. The radiology segment acconts for majority revenue.
Executives
Ronald J. Bienias officer: Chief Restructuring Officer C/O AKUMIN INC.,, 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Stonepeak Gp Investors Holdings Manager Llc 10 percent owner, other: See Remarks 55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Upper Holdings Lp 10 percent owner, other: See Remarks 55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Stonepeak Gp Investors Holdings Lp 10 percent owner, other: See Remarks 55 HUDSON YARDS, 550 WEST 34TH STREET, 48TH FLOOR, NEW YORK NY 10001
Krishna Kumar officer: See remarks C/O AKUMIN INC., 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Lawrence Ross Sinclair director 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
R. David Kretschmer officer: See Remarks 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Murray Lee director 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Scw Capital Management, Lp 10 percent owner 3131 TURTLE CREEK BLVD., SUITE 302, DALLAS TX 75219
Trinity Investment Group, Llc 10 percent owner 3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
Robert N. Cathey 10 percent owner 3131 TURTLE CREEK BLVD., #302, DALLAS TX 75219
John R. Wagner 10 percent owner 3838 OAK LAWN AVE., SUITE 450, DALLAS TX 75219
Paul Nelis officer: Chief Information Officer 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Haichen Huang director 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322
Matt Cameron officer: See Remarks 8300 W. SUNRISE BOULEVARD, PLANTATION FL 33322

Akumin (Akumin) Headlines

From GuruFocus

Akumin Announces First Quarter 2022 Results

By PRNewswire PRNewswire 06-19-2022

Akumin appoints President and Chief Operating Officer

By PRNewswire PRNewswire 06-12-2023

Akumin Announces Third Quarter 2022 Results

By PRNewswire PRNewswire 11-09-2022

Akumin Announces First Quarter 2022 Results

By PRNewswire PRNewswire 05-10-2022

Glassbeam appoints Rhonda Longmore-Grund as Chairman

By PRNewswire PRNewswire 05-09-2023

Akumin Announces Second Quarter 2022 Results

By PRNewswire PRNewswire 08-09-2022

Akumin Announces First Quarter 2022 Results

By PRNewswire PRNewswire 06-09-2022